Gene therapy for lung cancer
- 1 March 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 12 (2) , 138-142
- https://doi.org/10.1097/00001622-200003000-00007
Abstract
The advances that have been made over the past decade in the field of gene transfer as well as in the fields of immunology and the molecular biology of tumorigenesis have brought to reality the possibility of using gene transfer as an anti-cancer treatment modality. The published results of clinical trials using this approach to date have been very limited, and a considerable amount of work still needs to be done in order to make this an effective treatment modality. However the developments that have occurred in the past several years indicate that this modality will become efficacious in the foreseeable future.Keywords
This publication has 34 references indexed in Scilit:
- Human Gene Marker/Therapy Clincal Protocols (Complete Updated Listings)Human Gene Therapy, 1999
- Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Cancer Chemotherapy Using Suicide GenesSurgical Oncology Clinics of North America, 1998
- Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipientsThe Lancet, 1997
- The role of the bystander effect in suicide gene therapyEuropean Journal Of Cancer, 1997
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- Metabolic suicide genes in gene therapyPharmacology & Therapeutics, 1994
- In situ delivery of suicide genes for cancer treatmentEuropean Journal Of Cancer, 1994
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989